| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3997439 | Seminars in Breast Disease | 2008 | 6 Pages |
Abstract
In vivo proton magnetic resonance spectroscopy (1H MRS) is rapidly becoming useful as a clinical tool for diagnosing and characterizing breast cancers. Alterations of the levels of choline-containing metabolites are associated with malignancy. High-field MR scanners at 1.5 T, 3 T, 4 T, and 7 T have been used to evaluate the role of 1H MRS measurements of total choline-containing compounds in patients with breast cancer. This article will review clinical use of MRI/MRS in vivo. Newer developments in high field MR scanning and quantitative MRS may help breast imagers improve sensitivity and specificity in diagnosing and treating breast cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Michael T. MD, Lenore I. MD, Michael PhD, Tim MD, Patrick J. PhD,